Search research articles
Contact Us
Filters
Showing results (41-50 of 61) with videos related to
Page
of 7
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2009
The impact of primary tumour origins in patients with advanced oesophageal, oesophago-gastric junction and gastric adenocarcinoma--individual patient data from 1775 patients in four randomised controlled trials
I Chau, A R Norman, D Cunningham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 23, 1998
A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer
A Makris, T J Powles, S E Ashley, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 10, 2006
Efficacy and tolerability of chemotherapy in elderly patients with advanced oesophago-gastric cancer: A pooled analysis of three clinical trials
M Trumper, P J Ross, D Cunningham, et al.
Leukemia & Lymphoma
|
January 1, 1994
Fludarabine in lymphoproliferative disorders: the Royal Marsden Hospital experience
M E O'Brien, E Matutes, D Cunningham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1994
High-dose melphalan for multiple myeloma: long-term follow-up data
D Cunningham, L Paz-Ares, M E Gore, et al.
British Journal of Cancer
|
May 1, 1996
High-dose chemotherapy and autologous bone marrow transplant in relapsed Hodgkin's disease--a pragmatic prognostic index
M E O'Brien, S Milan, D Cunningham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 16, 2002
A multicentre, randomised phase III trial comparing protracted venous infusion (PVI) 5-fluorouracil (5-FU) with PVI 5-FU plus mitomycin C in patients with inoperable oesophago-gastric cancer
N C Tebbutt, A Norman, D Cunningham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2002
Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer
P Ross, M Nicolson, D Cunningham, et al.
British Journal of Cancer
|
June 12, 2003
Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer
A Saini, A R Norman, D Cunningham, et al.
British Journal of Haematology
|
August 8, 1998
A randomized trial of maintenance interferon following high-dose chemotherapy in multiple myeloma: long-term follow-up results
D Cunningham, R Powles, J Malpas, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 61) with videos related to
Sort By:
Page
of 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2009
The impact of primary tumour origins in patients with advanced oesophageal, oesophago-gastric junction and gastric adenocarcinoma--individual patient data from 1775 patients in four randomised controlled trials
I Chau, A R Norman, D Cunningham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 23, 1998
A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer
A Makris, T J Powles, S E Ashley, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 10, 2006
Efficacy and tolerability of chemotherapy in elderly patients with advanced oesophago-gastric cancer: A pooled analysis of three clinical trials
M Trumper, P J Ross, D Cunningham, et al.
Leukemia & Lymphoma
|
January 1, 1994
Fludarabine in lymphoproliferative disorders: the Royal Marsden Hospital experience
M E O'Brien, E Matutes, D Cunningham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1994
High-dose melphalan for multiple myeloma: long-term follow-up data
D Cunningham, L Paz-Ares, M E Gore, et al.
British Journal of Cancer
|
May 1, 1996
High-dose chemotherapy and autologous bone marrow transplant in relapsed Hodgkin's disease--a pragmatic prognostic index
M E O'Brien, S Milan, D Cunningham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 16, 2002
A multicentre, randomised phase III trial comparing protracted venous infusion (PVI) 5-fluorouracil (5-FU) with PVI 5-FU plus mitomycin C in patients with inoperable oesophago-gastric cancer
N C Tebbutt, A Norman, D Cunningham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2002
Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer
P Ross, M Nicolson, D Cunningham, et al.
British Journal of Cancer
|
June 12, 2003
Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer
A Saini, A R Norman, D Cunningham, et al.
British Journal of Haematology
|
August 8, 1998
A randomized trial of maintenance interferon following high-dose chemotherapy in multiple myeloma: long-term follow-up results
D Cunningham, R Powles, J Malpas, et al.
Page
of 7